Strategic partnership for amidites with Wuhu Huaren
In 2022 we have entered a strategic partnership with Wuhu Huaren Science and Technology Co., Ltd.
Through this cooperation, we combine state-of-the-art technical know-how with regulatory and GMP experience in over 60 countries around the world with our usual high level of quality consciousness and service orientation.
We successfully used the TIDES Europe conference in Hamburg to present Midas' products and services in the *Tides sector and present our strategic cooperation with Wuhu Huaren, a company offering simple and complex backwards integrated amidites.
It was the first event where Midas’ and Wuhu Huaren’s cooperation in the field of amidites for oligonucleotides was publicly presented.
We were able to showcase the added value of our partnership and our expertise in oligonucleotides building blocks in several joint meetings with well-known contacts as well as new customers.
It was an important step towards an even closer partnership looking forward to materializing our joint plans for 2025.
The conference offered numerous opportunities to learn about current trends and developments in the peptide and oligonucleotide (*tides) market. Over 80 sessions offered insights into new technologies and approaches for large industry and future research.
We look forward to further expanding this partnership and to a successful future.
Find out more about Oligonucleotides
Your Contact
Dr. Jasmin Hertler
International Division
Project Manager Intermediates for Pharma & BioPharma
Rheinstr. 49
55218 Ingelheim
Germany